Literature DB >> 11721169

Pamidronate-related nephrotoxicity (tubulointerstitial nephritis) in a patient with osteolytic bone metastases.

K Janssen van Doorn, B Neyns, P Van der Niepen, D Verbeelen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11721169     DOI： 10.1159/000046123

Source DB:  PubMed          Journal:  Nephron        ISSN： 1660-8151            Impact factor:   2.847


× No keyword cloud information.
  4 in total

1.  Nephrotic syndrome after oral bisphosphonate (alendronate) administration in a patient with osteoporosis.

Authors:  M Yilmaz; H Taninmis; E Kara; A Ozagari; A Unsal
Journal:  Osteoporos Int       Date:  2012-01-26       Impact factor: 4.507

2.  Nephrotic syndrome induced by pamidronate.

Authors:  M A G J ten Dam; L B Hilbrands; J F M Wetzels
Journal:  Med Oncol       Date:  2010-09-24       Impact factor: 3.064

3.  Nephronophthisis-like nephritis associated with fibrous dysplasia of bone.

Authors:  Justine Bacchetta; Roland Chapurlat; Raymonde Bouvier; Corinne Antignac; Laurence Dubourg; Rémi Kohler; Pierre D Delmas; Pierre Cochat
Journal:  Pediatr Nephrol       Date:  2008-05-30       Impact factor: 3.714

4.  Safe and tolerable one-hour pamidronate infusion for multiple myeloma patients.

Authors:  Dimitrios Chantzichristos; Björn Andréasson; Peter Johansson
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.